Greg Yap

Greg is a partner at Menlo Ventures, and focuses on life science and digital health technology investments. Prior to Menlo, Greg was entrepreneur-in-residence at Illumina Ventures, where he focused on new investments related to genomics, and CEO and cofounder of PyrAmes, a digital health company.

Previously, Greg was CEO and cofounder of Biodesy, a next-generation protein analysis company. Greg has also worked at Roche Diagnostics / Ventana, where he led a global market-leading cancer diagnostic assay business, serving 20 million patients and delivering $500 million revenue per year. Greg’s prior experience also includes roles as the first healthcare entrepreneur-in-residence at GE, chief operating officer at Cellpoint Diagnostics, an early liquid biopsy startup, vice president and general manager for genetics and molecular diagnostics at Affymetrix, and consultant for McKinsey & Company.

Greg received his AB in molecular biology (summa cum laude) from Princeton University, and his MBA from Stanford University’s Graduate School of Business. Greg is a Bay Area native and has lived in 11 cities in the area. He serves on the board of Outward Bound California, and loves all manner of outdoor activities with his family, including backpacking and snowboarding. His favorite sport is basketball.


Click here to download hi-res headshot.